HCWM
GILD icon

Harrison & Co Wealth Management’s Gilead Sciences GILD Stock Holding History

Harrison & Co Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.07M Sell
12,493
-188
-1% -$14.9K 1.04% 27
2022
Q3 		$782K Sell
12,681
-658
-5% -$41.5K 0.83% 47
2022
Q2 		$824K Buy
13,339
+657
+5% +$40.7K 0.78% 55
2022
Q1 		$754K Buy
12,682
+816
+7% +$52.2K 0.66% 64
2021
Q4 		$862K Buy
+11,866
New +$817K 0.73% 59

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harrison & Co Wealth Management's GILD Position: Q4 2022 in Review

Harrison & Co Wealth Management reduced its Gilead Sciences (GILD) stake by 1.5% in Q4 2022, selling an estimated $14.9K and leaving 12,493 shares worth $1.07M. The position accounts for 1.04% of the portfolio, ranked #27.

Harrison & Co Wealth Management first reported a position in GILD in Q4 2021 and has held it in 5 quarters since. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Harrison & Co Wealth Management held 12,493 shares of Gilead Sciences worth $1.07M as of Q4 2022.
  • Harrison & Co Wealth Management sold 188 Gilead Sciences shares in Q4 2022, an estimated $14.9K.
  • Gilead Sciences made up 1.04% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #27 holding.
  • Harrison & Co Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 5 quarters since.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.